Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global biological skin substitutes market 3600 synopsis, 2018 – 2032
2.2 Regional trends
2.3 Type trends
2.4 Application trends
2.5 End-use trends
Chapter 3 Biological Skin Substitutes Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing prevalence of chronic wounds
3.5.1.2 Rising number of burn & trauma cases
3.5.1.3 Growing adoption of wound care facilities
3.5.1.4 Technological advancements in regenerative medicine
3.5.2 Industry pitfalls & challenges
3.5.2.1 Adverse side effects associated with biological skin substitutes
3.5.2.2 Lack of reimbursement policies
3.6 Growth potential analysis
3.6.1 By type
3.6.2 By application
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Organogenesis Inc
4.1.2 Smith & Nephew plc
4.1.3 MiMedx Group, Inc.
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Biological Skin Substitutes Market Size and Forecast, By Type, 2018-2032 (USD Million)
5.1 Key trends, by type
5.2 Human donor tissue-derived products
5.3 Acellular animal-derived products
5.4 Tissue-engineered skin products
5.5 Biosynthetic skin products
Chapter 6 Biological Skin Substitutes Market Size and Forecast, By Application, 2018-2032 (USD Million)
6.1 Key trends, by application
6.2 Acute wounds
6.3 Chronic wounds
6.4 Other applications
Chapter 7 Biological Skin Substitutes Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Specialty clinics
7.5 Other end-users
Chapter 8 Biological Skin Substitutes Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Organogenesis Inc
9.2 Smith & Nephew plc
9.3 MiMedx Group, Inc.
9.4 Misonix, Inc.(Bioventus)
9.5 Avita Medical
9.6 Stratatech Corporation (Mallinckrodt Pharmaceuticals)
9.7 BioTissue
9.8 Aroa Biosurgery
9.9 ProgenaCare
9.10 Mimedx Group (MiMedx Group, Inc.)
9.11 Tissue Regenix
9.12 Stryker
9.13 Vericel Corporation
9.14 Integra LifeSciences
